Comparative efficacy of postoperative adjuvant transcatheter arterial chemoembolization versus lenvatinib plus tislelizumab in patients with BCLC stage 0 -B hepatocellular carcinoma after radical resection - Top-Institutions - MDSpire

Comparative efficacy of postoperative adjuvant transcatheter arterial chemoembolization versus lenvatinib plus tislelizumab in patients with BCLC stage 0 -B hepatocellular carcinoma after radical resection

  • By

  • Xu Feng

  • Yupei Ao

  • Lili Wang

  • Kai Chen

  • Chengjia Tang

  • Chengcheng Huang

  • June 29, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    Memorial Sloan Kettering Cancer Center
    Memorial Sloan Kettering Cancer Center

    New York, NY

    Key Differentiators

    • Hepatology

  • #2

    First Affiliated Hospital of Chongqing Medical University
    First Affiliated Hospital of Chongqing Medical University

    Chongqing, Chongqing

    Key Differentiators

    • Hepatobiliary Surgery

  • #3

    Affiliated Yongchuan Hospital of Chongqing Medical University
    Affiliated Yongchuan Hospital of Chongqing Medical University

    Chongqing, Chongqing

    Key Differentiators

    • Hepatobiliary Surgery

Original Source(s)

Comparative efficacy of postoperative adjuvant transcatheter arterial chemoembolization versus lenvatinib plus tislelizumab in patients with BCLC stage 0 -B hepatocellular carcinoma after radical resection

  • by Xu Feng, Yupei Ao, Lili Wang, Kai Chen, Chengjia Tang, Chengcheng Huang

  • June 29, 2026

Related Content

Mechanism of liposome arsenic trioxide regulating tumor microenvironment and sensitizing tumor immune response after radiofrequency ablation

Mixed adenoneuroendocrine carcinoma of the gallbladder: a case report and literature review

Non-gestational choriocarcinoma presenting as cervical lymphadenopathy in a male patient: a case report